sarnsrun/medquad huggingface dataset:
Topic: Childhood Astrocytomas
Question: Who is at risk for Childhood Astrocytomas? ?
Answer: Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesnt mean that you will not get cancer. Talk with your child's doctor if you think your child may be at risk. Possible risk factors for astrocytoma include:          - Past radiation therapy to the brain.    - Having certain genetic disorders, such as neurofibromatosis type 1 (NF1) or tuberous sclerosis.
Source: CancerGov
Topic: Childhood Astrocytomas
Question: What are the symptoms of Childhood Astrocytomas ?
Answer: The signs and symptoms of astrocytomas are not the same in every child. Signs and symptoms depend on the following:          - Where the tumor forms in the brain or spinal cord.    - The size of the tumor.    - How fast the tumor grows.    - The child's age and development.        Some tumors do not cause signs or symptoms. Signs and symptoms may be caused by childhood astrocytomas or by other conditions. Check with your child's doctor if your child has any of the following:         - Morning headache or headache that goes away after vomiting.    -  Nausea and vomiting.    - Vision, hearing, and speech problems.     - Loss of balance and trouble walking.     - Worsening handwriting or slow speech.    - Weakness or change in feeling on one side of the body.    - Unusual sleepiness.    - More or less energy than usual.    - Change in personality or behavior.    -  Seizures.    - Weight loss or weight gain for no known reason.     - Increase in the size of the head (in infants).
Source: CancerGov
Topic: Childhood Astrocytomas
Question: What is the outlook for Childhood Astrocytomas ?
Answer: Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) and treatment options depend on the following:         - Whether the tumor is a low-grade or high-grade astrocytoma.    - Where the tumor has formed in the CNS and if it has spread to nearby tissue or to other parts of the body.    - How fast the tumor is growing.    - The child's age.    - Whether cancer cells remain after surgery.    - Whether there are changes in certain genes.    - Whether the child has NF1 or tuberous sclerosis.    - Whether the child has diencephalic syndrome (a condition which slows physical growth).    - Whether the child has intracranial hypertension (cerebrospinal fluid pressure within the skull is high) at the time of diagnosis.    - Whether the astrocytoma has just been diagnosed or has recurred (come back).        For recurrent astrocytoma, prognosis and treatment depend on how much time passed between the time treatment ended and the time the astrocytoma recurred.
Source: CancerGov
Topic: Childhood Astrocytomas
Question: What are the stages of Childhood Astrocytomas ?
Answer: Key Points
                    - The grade of the tumor is used to plan cancer treatment.          - Low-grade astrocytomas     - High-grade astrocytomas        - An MRI is done after surgery.
                
                
                    The grade of the tumor is used to plan cancer treatment.
                    Staging is the process used to find out how much cancer there is and if cancer has spread. It is important to know the stage in order to plan treatment.    There is no standard staging system for childhood astrocytoma. Treatment is based on the following:          - Whether the tumor is low grade or high grade.    - Whether the tumor is newly diagnosed or recurrent (has come back after treatment).        The grade of the tumor describes how abnormal the cancer cells look under a microscope and how quickly the tumor is likely to grow and spread.   The following grades are used:     Low-grade astrocytomas    Low-grade astrocytomas are slow-growing and rarely spread to other parts of the brain and spinal cord or other parts of the body. There are many types of low-grade astrocytomas. Low-grade astrocytomas can be either:            - Grade I tumors pilocytic astrocytoma, subependymal giant cell tumor, or angiocentric glioma.     - Grade II tumors diffuse astrocytoma, pleomorphic xanthoastrocytoma, or choroid glioma of the third ventricle.            Children who have neurofibromatosis type 1 may have more than one low-grade tumor in the brain. Children who have tuberous sclerosis have an increased risk of subependymal giant cell astrocytoma.       High-grade astrocytomas     High-grade astrocytomas are fast-growing and often spread within the brain and spinal cord. There are several types of high-grade astrocytomas. High grade astrocytomas can be either:            - Grade III tumors anaplastic astrocytoma or anaplastic pleomorphic xanthoastrocytoma.      - Grade IV tumors glioblastoma or diffuse midline glioma.             Childhood astrocytomas usually do not spread to other parts of the body.
                
                
                    An MRI is done after surgery.
                    An MRI (magnetic resonance imaging) is done in the first few days after surgery. This is to find out how much tumor, if any, remains after surgery and to plan further treatment.
Source: CancerGov
Topic: Childhood Astrocytomas
Question: what research (or clinical trials) is being done for Childhood Astrocytomas ?
Answer: New types of treatment are being tested in clinical trials.
                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     Other drug therapy     Lenalidomide is a type of angiogenesis inhibitor. It prevents the growth of new blood vessels that are needed by a tumor to grow.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
Source: CancerGov
Topic: Metastatic Squamous Neck Cancer with Occult Primary
Question: What is (are) Metastatic Squamous Neck Cancer with Occult Primary ?
Answer: Key Points
                    - Metastatic squamous neck cancer with occult primary is a disease in which squamous cell cancer spreads to lymph nodes in the neck and it is not known where the cancer first formed in the body.    - Signs and symptoms of metastatic squamous neck cancer with occult primary include a lump or pain in the neck or throat.     - Tests that examine the tissues of the neck, respiratory tract, and upper part of the digestive tract are used to detect (find) and diagnose metastatic squamous neck cancer and the primary tumor.    - Certain factors affect prognosis (chance of recovery) and treatment options.
                
                
                    Metastatic squamous neck cancer with occult primary is a disease in which squamous cell cancer spreads to lymph nodes in the neck and it is not known where the cancer first formed in the body.
                    Squamous cells are thin, flat cells found in tissues that form the surface of the skin and the lining of body cavities such as the mouth, hollow organs such as the uterus and blood vessels, and the lining of the respiratory (breathing) and digestive tracts. Some organs with squamous cells are the esophagus, lungs, kidneys, and uterus. Cancer can begin in squamous cells anywhere in the body and metastasize (spread) through the blood or lymph system to other parts of the body.    When squamous cell cancer spreads to lymph nodes in the neck or around the collarbone, it is called metastatic squamous neck cancer. The doctor will try to find the primary tumor (the cancer that first formed in the body), because treatment for metastatic cancer is the same as treatment for the primary tumor. For example, when lung cancer spreads to the neck, the cancer cells in the neck are lung cancer cells and they are treated the same as the cancer in the lung. Sometimes doctors cannot find where in the body the cancer first began to grow. When tests cannot find a primary tumor, it is called an occult (hidden) primary tumor. In many cases, the primary tumor is never found.
Source: CancerGov
Topic: Metastatic Squamous Neck Cancer with Occult Primary
Question: What are the symptoms of Metastatic Squamous Neck Cancer with Occult Primary ?
Answer: Signs and symptoms of metastatic squamous neck cancer with occult primary include a lump or pain in the neck or throat. Check with your doctor if you have a lump or pain in your neck or throat that doesn't go away. These and other signs and symptoms may be caused by metastatic squamous neck cancer with occult primary. Other conditions may cause the same signs and symptoms.
Source: CancerGov
Topic: Metastatic Squamous Neck Cancer with Occult Primary
Question: What is the outlook for Metastatic Squamous Neck Cancer with Occult Primary ?
Answer: Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) and treatment options depend on the following:         - The number and size of lymph nodes that have cancer in them.    - Whether the cancer has responded to treatment or has recurred (come back).    - How different from normal the cancer cells look under a microscope.    - The patient's age and general health.        Treatment options also depend on the following:         - Which part of the neck the cancer is in.    - Whether certain tumor markers are found.
Source: CancerGov
Topic: Metastatic Squamous Neck Cancer with Occult Primary
Question: What are the stages of Metastatic Squamous Neck Cancer with Occult Primary ?
Answer: Key Points
                    - After metastatic squamous neck cancer with occult primary has been diagnosed, tests are done to find out if cancer cells have spread to other parts of the body.    - There are three ways that cancer spreads in the body.
                
                
                    After metastatic squamous neck cancer with occult primary has been diagnosed, tests are done to find out if cancer cells have spread to other parts of the body.
                    The process used to find out if cancer has spread to other parts of the body is called staging. The results from tests and procedures used to detect and diagnose the primary tumor are also used to find out if cancer has spread to other parts of the body.    There is no standard staging system for metastatic squamous neck cancer with occult primary. The tumors are described as untreated or recurrent. Untreated metastatic squamous neck cancer with occult primary is cancer that is newly diagnosed and has not been treated, except to relieve signs and symptoms caused by the cancer.
                
                
                    There are three ways that cancer spreads in the body.
                    Cancer can spread through tissue, the lymph system, and the blood:         - Tissue. The cancer spreads from where it began by growing into nearby areas.     - Lymph system. The cancer spreads from where it began by getting into the lymph system. The cancer travels through the lymph vessels to other parts of the body.     - Blood. The cancer spreads from where it began by getting into the blood. The cancer travels through the blood vessels to other parts of the body.
Source: CancerGov
Topic: Metastatic Squamous Neck Cancer with Occult Primary
Question: what research (or clinical trials) is being done for Metastatic Squamous Neck Cancer with Occult Primary ?
Answer: New types of treatment are being tested in clinical trials.
                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     Chemotherapy     Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy).        Hyperfractionated radiation therapy     Hyperfractionated radiation therapy is a type of external radiation treatment in which a smaller than usual total daily dose of radiation is divided into two doses and the treatments are given twice a day. Hyperfractionated radiation therapy is given over the same period of time (days or weeks) as standard radiation therapy.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
Source: CancerGov
Topic: Small Intestine Cancer
Question: What is (are) Small Intestine Cancer ?
Answer: Key Points
                    - Small intestine cancer is a rare disease in which malignant (cancer) cells form in the tissues of the small intestine.    - There are five types of small intestine cancer.    - Diet and health history can affect the risk of developing small intestine cancer.    - Signs and symptoms of small intestine cancer include unexplained weight loss and abdominal pain.    - Tests that examine the small intestine are used to detect (find), diagnose, and stage small intestine cancer.    - Certain factors affect prognosis (chance of recovery) and treatment options.
                
                
                    Small intestine cancer is a rare disease in which malignant (cancer) cells form in the tissues of the small intestine.
                    The small intestine is part of the bodys digestive system, which also includes the esophagus, stomach, and large intestine. The digestive system removes and processes nutrients (vitamins, minerals, carbohydrates, fats, proteins, and water) from foods and helps pass waste material out of the body. The small intestine is a long tube that connects the stomach to the large intestine. It folds many times to fit inside the abdomen.
                
                
                    There are five types of small intestine cancer.
                    The types of cancer found in the small intestine are adenocarcinoma, sarcoma, carcinoid tumors, gastrointestinal stromal tumor, and lymphoma. This summary discusses adenocarcinoma and leiomyosarcoma (a type of sarcoma).    Adenocarcinoma starts in glandular cells in the lining of the small intestine and is the most common type of small intestine cancer. Most of these tumors occur in the part of the small intestine near the stomach. They may grow and block the intestine.   Leiomyosarcoma starts in the smooth muscle cells of the small intestine. Most of these tumors occur in the part of the small intestine near the large intestine.    See the following PDQ summaries for more information on small intestine cancer:          -  Adult Soft Tissue Sarcoma Treatment     -  Childhood Soft Tissue Sarcoma Treatment     -  Adult Non-Hodgkin Lymphoma Treatment     -  Childhood Non-Hodgkin Lymphoma Treatment     -  Gastrointestinal Carcinoid Tumors Treatment     -  Gastrointestinal Stromal Tumors Treatment
Source: CancerGov
Topic: Small Intestine Cancer
Question: Who is at risk for Small Intestine Cancer? ?
Answer: Diet and health history can affect the risk of developing small intestine cancer. Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Risk factors for small intestine cancer include the following:         - Eating a high-fat diet.    - Having Crohn disease.     - Having celiac disease.    -  Having familial adenomatous polyposis (FAP).
Source: CancerGov
Topic: Small Intestine Cancer
Question: What are the symptoms of Small Intestine Cancer ?
Answer: Signs and symptoms of small intestine cancer include unexplained weight loss and abdominal pain. These and other signs and symptoms may be caused by small intestine cancer or by other conditions. Check with your doctor if you have any of the following:          - Pain or cramps in the middle of the abdomen.    - Weight loss with no known reason.     - A lump in the abdomen.     -  Blood in the stool.
Source: CancerGov
Topic: Small Intestine Cancer
Question: What is the outlook for Small Intestine Cancer ?
Answer: Certain factors affect prognosis (chance of recovery) and treatment options.The prognosis (chance of recovery) and treatment options depend on the following:          - The type of small intestine cancer.     - Whether the cancer is in the inner lining of the small intestine only or has spread into or beyond the wall of the small intestine.    - Whether the cancer has spread to other places in the body, such as the lymph nodes, liver, or peritoneum (tissue that lines the wall of the abdomen and covers most of the organs in the abdomen).    -  Whether the cancer can be completely removed by surgery.    - Whether the cancer is newly diagnosed or has recurred.
Source: CancerGov
Topic: Small Intestine Cancer
Question: What are the stages of Small Intestine Cancer ?
Answer: Key Points
                    - Tests and procedures to stage small intestine cancer are usually done at the same time as diagnosis.     - There are three ways that cancer spreads in the body.    - Cancer may spread from where it began to other parts of the body.    - Small intestine cancer is grouped according to whether or not the tumor can be completely removed by surgery.
                
                
                    Tests and procedures to stage small intestine cancer are usually done at the same time as diagnosis.
                    Staging is used to find out how far the cancer has spread, but treatment decisions are not based on stage. See the General Information section for a description of tests and procedures used to detect, diagnose, and stage small intestine cancer.
                
                
                    There are three ways that cancer spreads in the body.
                    Cancer can spread through tissue, the lymph system, and the blood:         - Tissue. The cancer spreads from where it began by growing into nearby areas.     - Lymph system. The cancer spreads from where it began by getting into the lymph system. The cancer travels through the lymph vessels to other parts of the body.     - Blood. The cancer spreads from where it began by getting into the blood. The cancer travels through the blood vessels to other parts of the body.
                
                
                    Cancer may spread from where it began to other parts of the body.
                    When cancer spreads to another part of the body, it is called metastasis. Cancer cells break away from where they began (the primary tumor) and travel through the lymph system or blood.         - Lymph system. The cancer gets into the lymph system, travels through the lymph vessels, and forms a tumor (metastatic tumor) in another part of the body.    - Blood. The cancer gets into the blood, travels through the blood vessels, and forms a tumor (metastatic tumor) in another part of the body.        The metastatic tumor is the same type of cancer as the primary tumor. For example, if small intestine cancer spreads to the liver, the cancer cells in the liver are actually small intestine cancer cells. The disease is metastatic small intestine cancer, not liver cancer.
                
                
                    Small intestine cancer is grouped according to whether or not the tumor can be completely removed by surgery.
                    Treatment depends on whether the tumor can be removed by surgery and if the cancer is being treated as a primary tumor or is metastatic cancer.
Source: CancerGov
Topic: Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
Question: Who is at risk for Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies? ?
Answer: The risk factors for childhood AML, childhood CML, JMML, and MDS are similar. Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesnt mean that you will not get cancer. Talk with your childs doctor if you think your child may be at risk. These and other factors may increase the risk of childhood AML, childhood CML, JMML, and MDS:         - Having a brother or sister, especially a twin, with leukemia.    - Being Hispanic.    - Being exposed to cigarette smoke or alcohol before birth.     - Having a personal history of aplastic anemia.    - Having a personal or family history of MDS.    - Having a family history of AML.    - Past treatment with chemotherapy or radiation therapy.    - Being exposed to ionizing radiation or chemicals such as benzene.    - Having certain genetic disorders, such as:               - Down syndrome.      -  Fanconi anemia.      -  Neurofibromatosis type 1.      -  Noonan syndrome.      -  Shwachman-Diamond syndrome.
Source: CancerGov